Marino et al. [31] investigated the potential of a radiomic analysis of both DCE-MRI and CESM of the breast for predicting tumor invasiveness, hormone receptor status (HR) and tumor grade in patients with primary breast cancer. The gene discussed is NR4A1; the disease is breast cancer.